
Ocugen
#7015
Rank
$577.1M
Marketcap
United States
Country

Dr. Shankar Musunuri M.B.A., MBA, Ph.D. (Co-Founder, Chairman & CEO)
Dr. Uday B. Kompella Ph.D. (Co-founder & Independent Director)
Dr. Vijay Tammara Ph.D. (Sr. VP of Regulatory & Quality)
Summary
History
Ocugen was originally established in 2011 as a joint venture between Punch Biotech and Bharat Biotech. During its initial years, Ocugen worked to develop a platform that focused on discovering and developing innovative therapeutic approaches for the treatment of a range of retinal diseases. This platform culminated in Ocugen's launch of the RNAi-based therapy Ocumination in July 2016.
Mission
Vision
Key Team
Ms. Jessica Crespo CPA, CPA (Chief Accounting Officer, Sr. VP of Fin. and VP of Corp. Controller & Treasurer)
Dr. Arun Upadhyay Ph.D. (Chief Scientific Officer)
Ms. Tiffany Hamilton M.B.A. (Head of Corp. Communications)
Ms. Zara Gaudioso (AVP, Head of HR & Chief of Staff)
Mr. Michael Shine (Sr. VP of Commercial)
Dr. Robert J. Hopkins FACP, M.D., M.P.H. (Chief Medical Officer)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Dr. Shankar Musunuri M.B.A., MBA, Ph.D. (Co-Founder, Chairman & CEO)
Dr. Uday B. Kompella Ph.D. (Co-founder & Independent Director)
Dr. Vijay Tammara Ph.D. (Sr. VP of Regulatory & Quality)
